Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network.
Carlucci PM, Preisinger K, Deonaraine KK, Zaminski D, Dall'Era M, Gold HT, Kalunian K, Fava A, Belmont HM, Wu M, Putterman C, Anolik J, Barnas JL, Furie R, Diamond B, Davidson A, Wofsy D, Kamen D, James JA, Guthridge JM, Apruzzese W, Rao D, Weisman MH; Accelerating Medicines Partnership in RA/SLE Network; Izmirly PM, Buyon J, Petri M.
Carlucci PM, et al. Among authors: gold ht.
Rheumatology (Oxford). 2024 Mar 26:keae189. doi: 10.1093/rheumatology/keae189. Online ahead of print.
Rheumatology (Oxford). 2024.
PMID: 38530774